2007•Thrombosis ResearchRequires access

Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism

Eva Solá, Amparo Vayá, Francisco España, Remedios Castelló, Luis Ramón, Antonio Hernández‐Mijares, Vicente Vicente, Amparo Estellés

Open publisher page 31 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 31 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Plasminogen activator, Plasminogen activator inhibitor-1, Internal medicine, Endocrinology, Body mass index, Obesity, Genotype, Medicine

Back to paper search Browse research topics Original source

Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism — Research Paper | ScholarLens